Status:
COMPLETED
A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Nasal Polyps
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol or spray is more effective in treatment of nasal polyps.
Detailed Description
Aqueous and aerosol delivery of intranasal corticosteroids has never been directly compared previously in patients with nasal polyps and it is unknown whether one is superior. This objective of this ...
Eligibility Criteria
Inclusion
- 18 years old
- New diagnosis of nasal polyps confirmed by two physicians
Exclusion
- Intranasal corticosteroid use within 4 weeks
- Oral corticosteroids use within 4 weeks
- Oral corticosteroid inhalation (ie for treatment of asthma or COPD) of Budesonide \>400ug daily, Fluticasone \>250ug daily, Beclomethasone \>400ug daily
- Contraindication to intranasal corticosteroid
- Inability to give informed consent
- Participation in another clinical trial
- Pregnancy (or not using effective method of contraception) or lactation
- Cystic fibrosis
Key Trial Info
Start Date :
November 23 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00788463
Start Date
November 23 2006
End Date
November 30 2011
Last Update
August 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergy Clinic, London Health Sciences Centre
London, Ontario, Canada, N6A 4G5